Table V.
Age <5 (n = 1279) | Age 5–14 (n = 8012) | Age >14 (n = 18 692) | P value | ||||
---|---|---|---|---|---|---|---|
AIDS | 0 | (0.0) | ≤10 | (<0.1) | 15 | (0.1) | .12* |
Anemia | 100 | (7.8) | 345 | (4.3) | 1544 | (8.3) | <.001 |
Rheumatoid arthritis/collagen vascular disease | 0 | (0.0) | 51 | (0.6) | 167 | (0.9) | .13* |
Chronic blood loss | ≤10 | (0.3) | 17 | (0.2) | 57 | (0.3) | .63 |
Congestive heart failure | ≤10 | (0.2) | ≤10 | (0.1) | 26 | (0.1) | .80 |
Chronic lung disease | 97 | (7.6) | 793 | (9.9) | 1561 | (8.4) | .005 |
Coagulopathy | 29 | (2.2) | 179 | (2.2) | 325 | (1.7) | .10 |
Depression | 0 | (0.0) | 133 | (1.7) | 1028 | (5.5) | <.001* |
Diabetes mellitus | 11 | (0.8) | 239 | (3.0) | 1454 | (7.8) | <.001 |
Diabetes with chronic complications | 0 | (0.0) | 25 | (0.3) | 142 | (0.8) | .001* |
Drug abuse | ≤10 | (0.1) | 29 | (0.4) | 861 | (4.6) | <.001 |
Hypertension | 32 | (2.5) | 255 | (3.2) | 903 | (4.8) | <.001 |
Hypothyroidism | 12 | (1.0) | 79 | (1.0) | 269 | (1.4) | .08 |
Liver disease | 25 | (1.9) | 265 | (3.3) | 670 | (3.6) | .06 |
Lymphoma | 0 | (0.0) | 20 | (0.2) | 35 | (0.2) | .44* |
Fluid and electrolyte disorders | 378 | (29.6) | 1576 | (19.7) | 3815 | (20.4) | <.001 |
Metastatic cancer | ≤10 | (0.4) | ≤10 | (0.1) | 15 | (0.1) | .035 |
Neurologic disease | 111 | (8.7) | 531 | (6.6) | 575 | (3.1) | <.001 |
Paralysis | 48 | (3.8) | 333 | (4.2) | 282 | (1.5) | <.001 |
Peripheral vascular disorders | ≤10 | (0.1) | 13 | (0.2) | 40 | (0.2) | .80 |
Psychoses | ≤10 | (0.1) | 150 | (1.9) | 588 | (3.2) | <.001 |
Pulmonary circulation disorders | ≤10 | (0.8) | 13 | (0.2) | 40 | (0.2) | .002 |
Renal failure | 12 | (0.9) | 78 | (1.0) | 185 | (1.0) | .99 |
Solid tumor without metastasis | ≤10 | (0.1) | 11 | (0.1) | 16 | (0.1) | .64 |
Peptic ulcer disease | 0 | (0.0) | 0 | (0.0) | ≤10 | (<0.1) | — |
Valvular disease | ≤10 | (0.7) | 24 | (0.3) | 47 | (0.3) | .06 |
Weight loss | 23 | (1.8) | 169 | (2.1) | 517 | (2.8) | .016 |
Values are n (%).
P value excludes youngest age group.